Newfound protein may prevent viral infection and herpes-induced cancer

Newfound protein may prevent viral infection and herpes-induced cancer
The researchers found a protein that helps prevent human herpes virus 8 from replicating by detecting a specific modification on viral messenger RNA. Credit: Brandon Tan

Keck School of Medicine of USC researchers have identified a human protein that could prevent cancer by restricting a type of herpes virus from replicating.

The scientists examined the human herpes virus 8, otherwise known as Kaposi's sarcoma-associated herpesvirus. Kaposi sarcoma is a cancer that causes lesions in soft tissue, including skin, the oral cavity, lymph nodes and internal organs.

Shou-Jiang Gao, senior author of the study, has been studying this eighth type of herpes viruses for almost 25 years. The current study, published in Nature Microbiology on Nov. 6, is the first to map healthy cells and those infected by a large DNA virus, Gao said.

"Understanding how the herpes virus switches from being dormant to causing cancer is important because of the health problems the herpes virus causes worldwide," said Gao, a professor of molecular microbiology and immunology at the Keck School of Medicine.

More than 3.7 billion people under 50 years old—67 percent of the population—are infected with two common herpes viruses that cause or cold sores around the mouth, according to the World Health Organization.

Most herpes viruses remain dormant until someone's immune system weakens due to factors such as age or a disease like or HIV. When the immune system cannot keep diseases in check, some of these herpes viruses can cause cancers.

"The findings from this study can potentially be translated into novel therapeutic approaches for cancers that are caused by ," Gao said.

Kaposi sarcoma is more common among people with HIV, transplant recipients and men of African descent. In some areas of Africa, more than 90 percent of the population shows signs of herpes virus 8 infection, according to the American Cancer Society.

Roadmap to cure viral-induced cancer

Scientists looked at messenger RNAs, which carry genetic messages from DNA to help make proteins—long chains of amino acids that form structural components of body tissue such as muscle and hair. Specifically, they studied N6-methyladenosine (m6A) and N6, 2-O-dimethyladenosine modifications to messenger RNAs.

Through mapping proteins that can restrict viral infections, the researchers found a protein called YTHDF2 that can help regulate the 8 by detecting the m6A modification on viral messenger RNA. The protein is the key switch that regulates human 8 replication.

"How the virus infects and replicates has a direct influence on how the cell becomes a cancer cell," Gao said, adding that you cannot cure cancer without some kind of roadmap. "If a person has a disease and the problem area is in the hand, you wouldn't want to treat the head. That's why you need to map the disease pathway. In this case, the YTHDF2 protein detects the m6A modifications on messenger RNAs."


Explore further

Chimera viruses can help the fight against lymphomas

More information: Brandon Tan et al. Viral and cellular N6-methyladenosine and N6,2′-O-dimethyladenosine epitranscriptomes in the KSHV life cycle, Nature Microbiology (2017). DOI: 10.1038/s41564-017-0056-8
Journal information: Nature Microbiology

Citation: Newfound protein may prevent viral infection and herpes-induced cancer (2017, November 28) retrieved 19 May 2019 from https://phys.org/news/2017-11-newfound-protein-viral-infection-herpes-induced.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
462 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more